Navigation Links
REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis
Date:9/23/2011

the past 17 years and through commercial experience with more than 1.5 million patients treated worldwide.

In the U.S., REMICADE® is approved for the following indications:

  • Reducing signs and symptoms, inhibiting the progression of structural damage and improving physical function in patients with moderately to severely active RA, when administered in combination with methotrexate.  
  • Reducing signs and symptoms in patients with active ankylosing spondylitis.
  • Reducing signs and symptoms and inducing and maintaining clinical remission in adult and pediatric patients with moderately to severely active Crohn's disease who have had an inadequate response to conventional therapy.  
  • Reducing the number of draining enterocutaneous and rectovaginal fistulas and maintaining fistula closure in adult patients with fistulizing Crohn's disease.  
  • Reducing signs and symptoms, inducing and maintaining clinical remission and mucosal healing, and eliminating corticosteroid use in patients with moderately to severely active UC who have had an inadequate response to conventional therapy.
  • Reducing signs and symptoms of active arthritis, inhibiting the progression of structural damage and improving physical function in patients with psoriatic arthritis.  
  • Treatment of adult patients with chronic severe plaque psoriasis who are candidates for systemic therapy and when other systemic therapies are medically less appropriate.

REMICADE® is unique among available anti-TNF-alpha biologic therapies.  It is the only anti-TNF-alpha biologic administered directly by caregivers in the clinic or office setting.  REMICADE® is a two-hour infusion administered every 6 or 8 weeks (indication-dependent), following a standard induction regimen that requires treatment at weeks 0, 2 and 6.  As a result, REMICADE® patients may require as few
'/>"/>

SOURCE Janssen Biotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement
2. Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication
3. FDA Advisory Committee Recommends Approval of REMICADE® for Treatment of Pediatric Ulcerative Colitis
4. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
5. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
8. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
9. CryoCor Receives FDA Approval for Right Atrial Flutter
10. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
11. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... March 3, 2015  Cumberland Pharmaceuticals Inc. (NASDAQ: ... on hospital acute care and gastroenterology, today announced ... Company,s revenue grew 15% in 2014 to $37 ... or $0.35 per diluted share. At the end ... $95 million including $55 million in cash and ...
(Date:3/3/2015)... , March 3, 2015  This industry report package offers the most ... for safety glass in the world and in the top 10 global ... country reports from the following countries: Australia ... Germany , Italy , Japan ... United Kingdom , United States ...
(Date:3/3/2015)... , March 3, 2015  BioPharmX Corporation (OTCQB: BPMX), ... novel drug delivery products to address unmet needs in ... Jim Pekarsky , chief executive officer and co-founder of ... Roth Capital Partners Conference on Wednesday, March 11 at ... Niguel in Dana Point ...
Breaking Medicine Technology:Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 2Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 3Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 4Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 5Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 6Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 7Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 8Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 9Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 10Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 11Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 12Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 13Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 14Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 15Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 16Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 17Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 18Global Safety Glass Market to 2019 - Market Size, Top 10 Countries, Trends, and Forecasts 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 3
... 2007 - Amgen,(NASDAQ: AMGN) today announced ... a,randomized, double-blind, placebo-controlled, multicenter Phase 3,study ... previously untreated,patients with extensive-stage small-cell lung ... demonstrated,no statistically significant difference in risk ...
... CAMBRIDGE, Mass., April 18, 2007 /PRNewswire-FirstCall/ --,Idenix Pharmaceuticals, ... development and commercialization of drugs for,the treatment of ... 11 abstracts have been accepted for,presentation at the ... in Washington D.C. from May 19 to 24. ...
Cached Medicine Technology:Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 2Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 3Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 4Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 5Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 6Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 7Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting 2Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting 3Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting 4Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting 5Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting 6Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting 7
(Date:3/4/2015)... Nike Swim Camps offer outstanding coaching ... is to stimulate a love of swimming in a ... campers the opportunity to train with some of the ... Vice President of US Sports Camps. “Our program directors ... build confidence and improve their technique.” , Nike Swim ...
(Date:3/4/2015)... Jose, California (PRWEB) March 04, 2015 ... devices that are used to draw milk from the breast ... the purpose of storage and use for feeding the baby. ... due to medical complications, premature birth, or the mother being ... day because of work, among others. Breast pumps are also ...
(Date:3/4/2015)... March 04, 2015 Ada Products ... announced on Wednesday its strategic partnership with the Dental ... tools that will introduce them to engaging, inspiring ideas, ... dentistry. , The Dental Exchange is a ... the dental industry. Unlike other social platforms, the Dental ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 ... is witnessing strong growth worldwide, supported by the ... of robot-assisted surgery and single incision surgery will ... benefits of minimally invasive surgery, driving its adoption ... to the surgical site, lower blood loss, shorter ...
(Date:3/4/2015)... CA (PRWEB) March 04, 2015 Bird ... commercial, industrial and residential applications now offers its popular ... , The humane, highly efficient bird deterrent ... to match the color and décor of the building ... standard colors—brick red, white, crystal clear, light grey, brown, ...
Breaking Medicine News(10 mins):Health News:US Sports Camps and Nike Swim Camps Announce the 2015 Swim Camps Lineup 2Health News:Increase in the Number of Nursing Mothers in the Workplace Spurs the Breast Pumps Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Increase in the Number of Nursing Mothers in the Workplace Spurs the Breast Pumps Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Ada Products Company, Inc. Announces Strategic Partnership with the Dental Exchange 2Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Plastic Bird Spikes Now Come in 7 Colors to Blend in With Their Surroundings 2
... , , LONG BEACH, Calif., Sept. ... in this system is you. All I ask in return for using my ... can," said Bob Ainuu Afamasaga. , , "Millions of ... in mind because, as I have already said several times, creating debt is no ...
... WASHINGTON, Sept. 10 Immediately after President Obama,s speech to ... surveyed 44 of the nation,s top political, legislative and communications ... government, media consulting, lobbying, and public relations. , , ... "Democrats were very happy with the speech, but ...
... ... Reporting is Critical to Making Telecom Environments More Efficient and Effective , ... Phoenix, AZ ... provide effective telecom expense management (TEM) reporting according to the latest ...
... ... to Accelerate EHR Adoption by Guaranteeing Compliance with Federal Stimulus Reimbursement Requirements and ... ... outpatient information solutions, today announced the Vision Electronic Health Record (EHR) Compliance Guarantee ...
... ... from individuals and couples who have been receiving less than adequate information. Our purpose ... are seeking help with their infertility," states Surrogacy Lawyer Theresa M. Erickson. , ... San Diego and Los Angeles, CA (PRWEB) ...
... , , , , ... Bulletin Board: OXBO) has posted a new Blog entry by company chairman and ... stock split. , , The Blog is available via a ... as via the Shareholder Forum link on the Investor Relations page of the ...
Cached Medicine News:Health News:$0.00 Penny System to Jump Start Global Economy Developed by DNA and MIND Researcher. 2Health News:Clarus Research Group Survey: Top Political Strategists React to Obama's Health Care Speech, Rate Effectiveness 2Health News:Clarus Research Group Survey: Top Political Strategists React to Obama's Health Care Speech, Rate Effectiveness 3Health News:New AOTMP Research Reveals that 21% of Enterprises Don't Have or Don't Know if they Have Telecom Expense Management Reporting 2Health News:SourceMedical Driving ASC Electronic Health Record Adoption through Compliance Guarantee and Financing Program 2Health News:SourceMedical Driving ASC Electronic Health Record Adoption through Compliance Guarantee and Financing Program 3Health News:California Surrogacy and Egg Donation Professionals Team Up -- Free Egg Donation Cycle 2Health News:California Surrogacy and Egg Donation Professionals Team Up -- Free Egg Donation Cycle 3Health News:California Surrogacy and Egg Donation Professionals Team Up -- Free Egg Donation Cycle 4
Universal, clear, lightweight plastic with smooth edges & ventilation holes for patient comfort...
... exercise BP monitor is designed to automatically ... diastolic BP along with heart rate. It's ... use in treadmill, ergometer and pharmacological stress ... use in research environments., ,Tango excels ...
...
... TraceMasterVue is a cutting-edge ECG ... thin-client functionality and convenient, web-based ... administrative and information technology (IT) ... lower costs, and improved patient ...
Medicine Products: